Vertex's Telaprevir Works In Twice Daily Dose; Response-Guided Therapy Cuts Down Drop-Outs
This article was originally published in The Pink Sheet Daily
Executive Summary
Is it a trick or a treat? AASLD lifts embargo on all annual meeting data at Halloween press conference.